来自:中国糖尿病杂志 编辑:罗樱樱 纪立农 翁建平 胡大一 潘长玉 |点击数:|2015-03-26
【摘要】目的 了解中国T2DM患者阿司匹林的使用情况。方法 选取自2010年8月至2011年3月在全国6个不同地区、104家不同级别医院就诊的T2DM患者25454例,根据既往病史将研究对象分为心脑血管事件一级预防组(n=19757)和二级预防组(n=5697)。按照中华医学会糖尿病学分会《中国2型糖尿病防治指南(2010版)》的推荐,计算各人群中阿司匹林的实际使用率。 结果 整体人群的阿司匹林使用率为18.78%。其中,推荐采用心脑血管事件一级预防人群的阿司匹林使用率为13.87%,需医师临床判断是否采用一级预防人群的阿司匹林使用率为11.19%;不推荐采用一级预防人群的阿司匹林使用率为6.43%。有心脑血管病史的二级预防人群的阿司匹林使用率为39.72%。结论 阿司匹林在中国T2DM患者预防心脑血管事件中整体使用率偏低。
【关键词】糖尿病,2型;阿司匹林;心脑血管事件;一级预防;二级预防
【Abstract】 Objective To investigate the use of aspirin for primary and secondary prevention of cardiovascular and cerebrovascular diseases in Type 2 Diabetes in China. Methods A total of 25,454 chinese adults with type 2 diabetes were enrolled at 104 hospitals of 6 regions from August 2010 to March 2011. All patients were divided into two groups, primary prevention group (n = 19757) or secondary prevention group (n = 5697) based on the history of cardiovascular or cerebrovascular diseases(CVD).According to the recommendation in Chinese type 2 diabetes guideline(2010) from Chines Diabetes Society, we calculate the percentage of people who are taking Aspirin as either primary or secondary prevention. Results 18.78% of all patients were taking aspirin. In primary prevention population, according to Chinese type 2 diabetes guideline(2010) , only 13.87% of the patients who should be recommended to take aspirin as primary preventionhave really been put on aspirin. 11.19% of the patients who should be recommended aspirin after the physician’s judgment were taking aspirin as primary prevention. However, 6.43% of the patients who should not take aspirin as primary prevention were also taking aspirin. In those who have the established CVD events, only 39.72% the patients were taking aspirin as a secondary prevention strategy. Conclusion The standardized use of aspirin as either primary or secondary prevention strategy for cardiovascular eventsintype 2 diabetes in China is really poor. We have to make our effort to improve the standardazaion treatment in type 2 diabetes patients in order to reduce their complications.
【Key words】 Diabetes mullitus,type 2;Aspirin;Cardiovascular and cerebrovascular events; Primary prevention;Secondary prevention
版权所有:《中国糖尿病杂志》社 主管单位:中华人民共和国教育部 主办单位:北京大学
地址:北京市西城区大红罗厂街1号 邮编:100034 电话(传真):010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持:九度创想